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Urticaria is frequently a perplexing problem, and with the
exception of those patients whose disease disappears quite
rapidly, the question of etiology and treatment is often difficult.
In a like manner atopic dermatitis often causes great concern for
both the patient and the doctor, and, as yet, a dependable therapy
for many cases of either condition has not been discovered.
The purpose of this communication is to give the results of the
use of histaminase in a small selected series of urticaria and atopic
dermatitis. Unfortunately the amount of drug at our disposal
was small, and so the report must be looked upon as preliminary.
It is our hope to continue this work with a much larger group
so that the results may be more convincing.
Many observers have suspected that the exudative reaction or spasm of
smooth muscle characterizing various forms of hypersensitiveness are produced
by the liberation of one or more chemical substances at the time of union of the
antigen and antibody. Of all investigated substances histamine produces symp-
toms most resembling those of anaphylactic shock when injected into animals in
toxic doses. As Tuft (1) stated, it seems more than mere coincidence that a
simple chemical substance such as histamine can so closely imitate the symptoms
of anaphylaxis.
Important experiments concerning histamine or a histamine-like substance
(H-substance) in conditions of hypersensitiveness were carried out by Lewis (2),
whose work dealt with the local vascular reactions of the skin to diverse stimuli.
Lewis showed that regardless of the type of stimulus the skin reacted with a
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"triple response" consisting of: first an erythema due to local vasodilatation,
second a diffuse flare caused by widespread relaxation of the neighboring arterioles
and third a wheal produced by increased permeability of the vessel walls. The
wheal was confined to the area of primary erythema. The identical typical re-
sponse produced by merely stroking the skin of a person with dermographism
could be reproduced by pricking a dilute solution of histamine into the skin.
Therefore Lewis concluded that a diffusible substance either similar to or identical
with histamine produced the local vasodilatation and wheal formation.
Subsequently Dale (3) showed that histamine was present in a large number
of organs and tissues of the body, being apparently inert while in the cell but
becoming active after being released by appropriate stimuli into the tissue fluids.
In 1925 Manwaring, Hosepian, Enright and Porter (4) showed by experiments
on anaphylaxis in dogs that following contact with an antigen, injured cells,
probably in the liver, liberated a histamine-like substance which caused con-
tractions of certain smooth muscle structures (uterus, bladder and intestine).
Their conclusions were based on the fact that blood taken from the liver of a dog
in anaphylactic shock caused a similar syndrome when injected intravenously
into a normal dog.
In 1932 Bartosch, Feldberg and Nagel (5), after extensive experiments on
guinea pigs, found that after flooding the lung of a sensitized animal with antigen
a substance could be isolated which had properties identical with those of his-
tamine. The appearance of the substance depended upon the antigen-antibody
reaction rather than upon other factors such as bronchial constriction, cessation
of respiration or circulatory changes.
In the same year Dragstedt and Gebauer-Fuelnegg (6a) concluded from their
experiments that in the majority of cases of severe or fatal anaphylactie shock in
dogs a histamine-like substance could be recovered from the supradiaphragmatic
vena cava and thoracic lymph duct. After further study (6b) the authors con-
cluded that the substance was actually histamine.
Roth and Horton (7) in studying physical allergy found an increase in the gas-
tric acids following immersion in cold water of the hand of a patient sensitive to
cold. The increase strikingly paralleled that produced by the injection of 0.38
mgm. of histamine. The experiments of Roth and Horton suggested that the
systemic reactions in patients hypersensitive to cold are caused by the absorption
of histamine released in the cooled skin.
The possible importance of histamine in persons sensitive to cold is likewise
indicated by the favorable response of such individuals to injections of histamine
as reported by Bray (8).
Goodson (9), after surveying the subject of "physical allergy" formed the
opinion that the urticarial wheals and some of the other manifestations of these
forms of "allergy" might well be due to the presence of histamine in the tissues in
greater amounts than can be dealt with by its physiologic antagonists.
Barsouni and Smirk (10) in 1936 measured increased amounts of H-substance
in human blood taken from an arm undergoing reactive hyperemia to circulatory
arrest. The authors believed that the liberation of the histamine-like substance
during circulatory arrest accounted at least in part for the hyperemia. Code
and lug (11) have since shown that the histamine activity of the blood is actually
due to histamine itself which can be extracted chemically from the white cells.
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Such experiments also suggest that histamine already present in the tissues may
be released by certain stimuli to give rise to abnormal reactions in the body.
Lewis (2) maintained that in urticaria there is an outpouring of H-substance
into the tissues producing the characteristic wheals. The release of H-substance
may be brought about either by external trauma or circulating noxae. Whether
or not the substance is actually histamine is not definitely known.
Tuft (1) stated that of all the theories offered to explain the mechanism of
allergic reactions in humans, that which involves the interaction between an
allergen and reagin resulting in the formation or liberation of histamine or a
histamine-like substance is the one most commonly accepted.
HISTAMINASE
Best (12) in 1929 noted the presence of a histamine inactivating
substance in tissues when he demonstrated that ox or horse lung
and other tissues (liver and kidney) caused the disappearance of
naturally occurring or added histamine when the tissues were
suspended in saline and incubated in the presence of toluene at
37°C. The experiments indicated that the histamine inactivat-
ing process might be an oxidative one. In 1930 Best and Mc-
Henry (13) investigated the question further emphasizing the
fact that the transient effects following the intravenous or sub-
cutaneous injection of small or moderate doses of histamine also
suggest that the body may possess an efficient means of elimina-
tion or inactivation of the substance. It has also been shown
that very little histamine can be recovered from the urine even
after the intravenous injection of large doses. Best and Mdllenry
found that the properties of the histamine inactivating substance
are those characteristic of enzymes and suggested the name
histaminase for the material which under experimental conditions
produces a change in structure of the histamine molecule which is
responsible for the loss of the physiologic activity of the amine.
A study of the distribution of histaminase in the dog indicated
that the kidneys and intestine are the richest source of the enzyme
in this species. Their work indicated that histaminase produces
a rupture of the iminazole ring in the histamine molecule since in
test solutions the loss of iminazole content roughly parallelled
the loss of histamine. They admitted however that little is
really known about the mechanism of the histamine-histaminase
reaction and that it might be either physical or chemical. They
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also stated that since it had not been established definitely that
histamine is the causative agent in any pathologic condition there
was at that time no obvious clinical application even though it
should be established that the ability of an organism to inacti-
vate histamine can be increased by the administration of the
enzyme.
Scholer's (14) work in 1933 suggested the presence of an anti-
allergic principle in the intestine. In experiments with rabbits
he produced local anaphylaxis (Arthus phenomenon) by the ap-
plication of antigen to the stomach tissue, conjuctiva or skin of a
sensitized animal while the similar application to the small
intestine or appended mesentery produced no such reaction. He
concluded that the intestinal mucosa possesses a distinct anti-
allergic principle the chemical nature of which is unknown.
This protective or anti-allergic substance derived from the small
intestine of the hog has been isolated and made available in a
form suitable for peroral and parenteral administration. Ac-
cording to the manufacturers (15), histaminase or "Torantil"
as it has been termed in Europe, is a protein-like material respond-
ing to chemical reactions common to albumins. It is a loose,
,white, stable powder, soluble in water, but showing a slight
opalescent tinge after being dissolved. Histaminase is available
in ampules, each dose representing 1 histamine detoxifying unit,
and in tablets of 5 histamine detoxifying units. One unit repre-
sents the quantity of histaminase which is capable of detoxifying
1 milligram of histamine hydrochloride during 24 hours at a
temperature of 37°C. The tablets are provided with a special
coating which is insoluble in the gastric juice, so that the effect
of the histaminase is exerted in the intestine.
In this preliminary report no attempt is made to completely
review the literature concerning the clinical use of histaminase.
Only a few pertinent articles will be cited with special reference
to the use of the substance in dermatology.
Rigler (16) in 1936, stated that in his opinion histaminase has
a desensitizing action on allergic conditions when administered
parenterally or orally and that the product should aid greatly in
solving the problem of allergy and intestinal intoxication.
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W. Ercklentz and B. W. Ercklentz (17) in the same year wrote
concerning the detoxifying and histamine-inactivating properties
of histaminase. They felt that it was of great benefit in the
treatment of gastritis, peptic ulcer, colitis, cirrhosis of the liver
and asthma.
Moldenschardt (18), also in 1936, reported good results follow-
ing the use of histaminase in gastric and duodenal ulcers, ulcera-
tive colitis, and cirrhosis of the liver. Seborrheic eczema,
pyoderma, and a case of primrose dermatitis also responded
favorably. A case of angioneurotic edema was benefitted and
in a case of serum sickness the writer gained the impression
that the rapid subsidence of the eruption was brought about
by injections of histaminase.
Urbach (19) also noted the successful treatment of a severe
case of purpura in a woman aged 31 following the use of histami-
nase. The disease had not been influenced previously by the
administration of vitamin C. TJrbach concluded that in this
instance the purpura was attributable to a deficient detoxifying
function of the intestine. In discussing the patient Matras
mentioned a case of chronic urticaria which had not been bene-
fitted by injections of histaminase. Its oral use had not been
tried.
Hartmann (20), in 1938, used histaminase in 25 severe cases of
acne vulgaris, each of which had been fruitlessly treated for years
by the commonly accepted therapeutic methods. The beneficial
results were said to be astounding. The author stated that
although the cause of acne is unknown there is basis for the belief
that endocrine imbalance and metabolic disturbances play an
important part. The histaminase was thought to have aided
in the detoxification of substances in the digestive tract, which if
absorbed, might produce a change in the skin, lowering its resist-
ance to bacteria and hence leading to acne.
In 1937 Roth and Horton (6) reported distinct improvement
following the administration of histaminase in a case of hyper-
sensitiveness to cold. The patient before treatment developed
swelling of the hand following its immersion in water at 10°C.
for 7 minutes. Within a period of ft days 67 units of histaminase
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were given following which only 2 finger tips became swollen
after the cold test in contrast to swelling up to the line of im-
mersion previous to treatment. Histaminase also caused disap-
pearance of abdominal distress of which the patient had com-
plained following exposure to cold.
At a recent meeting of the Central Society for Clinical Research
Foshay (21) reported on the effective treatment and probable
prophylaxis of serum sickness by means of histaminase. Twenty
patients were selected at random, most of whom presented a
severe form of the disorder. Thirteen of 16 patients who were
treated in the first or second day of the illness obtained relief
in from 18 to 36 hours or less and in most cases the clinical re-
sponses were actually dramatic. Attempts at prophylaxis seemed
extremely hopeful. Foshay commented that the treatment
seemed rational, highly effective, safe and devoid of untoward
by effects or after effects.
In discussing this work, Prickman stated that his results in
the use of histaminase in vasomotor rhinitis were not outstand-
ing (34 per cent relief). Roth reported that she was continuing
to obtain good results in the treatment of hypersensitiveness to
cold as well in hypersensitiveness to insulin. Foshay mentioned
in closing the discussion that he knew of one patient with angio-
neurotic edema whose swelling was greatly reduced while he was
taking histaminase but who again developed edema 9 to 14 hours
after the cessation of injections or oral administration.
OUR OWN EXPERIENCE WITH HISTAMINASE
We began using histaminase in the treatment of urticaria in
1937 and have continued to administer it in selected cases since
them. This study was limited to cases of several weeks' duration
of which the cause could not be determined and which had proved
refractory to the usual therapeutic measures such as calcium,
ephedrine, adrenalin, autohemotherapy, strontium bromide etc.
An attempt was made to exclude cases of which the causes were
obvious and those of short duration which might well have in-
voluted spontaneously or under the influence of various other
forms of treatment. The patients receiving histaminase were
given no other treatment. Papular urticaria was entirely ex-
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eluded from the study. In most instances histaminase was given
both by intramuscular injections 1 to 3 times weekly as well as
by mouth, 2 or 3 tablets three times daily. No unfavorable
reactions to the drug were noted.
On several occasions the investigation was interrupted on ac-
count of the difficulty of obtaining a sufficient supply of the
medication; and for this reason the number of cases which were
TABLE 1
Urticaria—17 cases
REsuur REMARKS
Clinically 10 (59%) In the cured cases the duration of treatment varied
cured from 4 days to 3 weeks. Average time for cure
10.7 days
Improved 2 (12%) One patient had urticaria for 9 months and was 50 per
cent improved in 3 weeks. The second patient had
urticaria for several years and was 90 per cent im-
proved after 2 months treatment
Unimproved 5 (29%) In the unimproved cases the durations were: 1, several
weeks; 2, several weeks; 3, five months; 4, two years;
5, three and a half years
TABLE 2
Urticaria factitia—P2 cases
No benefit in either case. One treated 3 weeks, the other 6 weeks.
TABLE 3
Atopic dermatitis—8 cases
No definite improvement in any. One month's trial of histaminase given,
either without local therapy or without change in local therapy in use at the
time of institution of histaminase.
studied is small. When an adequate supply of histaminase is
again available we plan to continue the investigation in order
that more definite conclusions can be drawn. For brevity the
results are given in the tables 1 to 3.
COMMENT
On account of the small number of cases treated with histami-
nase no definite conclusions can be drawn concerning its value in
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the treatment of urticaria. Our impression at this time how-
ever is that histaminase has some value in the treatment of the
disease. It should be recalled that our 17 cases were of relatively
long duration and had in most instances proved refractory to the
usual therapeutic measures. In selecting our cases we kept in
mind the fact that ordinary acute urticaria is a capricious disease
and frequently undergoes spontaneous involution thus rendering
difficult the appraisal of any particular type of treatment. These
cases were not given histaminase until other measures had failed.
As is usually the case in other types of therapy, histaminase
proved of no value in the 2 dermographic patients whom we
treated.
One month's trial of the drug was given in the 8 cases of atopic
dermatitis and in none was there enough improvement to warrant
giving any credit to histaminase. In atopic dermatitis we believe
that some degree of benefit should have been noticed within a
month had the drug possessed much value in this disease. None
of the patients were given dietary restrictions, sedatives or
roentgenotherapy while taking histaminase. In most cases no
local therapy was given; in a few others who had been using a
certain external application for some time the histaminase was
merely added.
From our small series we feel that it is permissible to state that
histaminase is a useful adjunct to other therapeutic measures in
urticaria and that further studies in which the cases are not
limited to chronic resistant ones, may prove that the drug is of
considerable value.
We do not feel justified to conclude that the favorable results
are due to inactivation of histamine, yet we cannot deny the
possibility. We must simply face the facts and admit that the
nature of whatever anti-allergic properties histaminase possesses
are as yet not definitely known.
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DISCUSSION
DR. PAUL A. O'LEARY, Rochester, Minn.: I have been interested in the use of
histamine in the urtiearia group, in those with atopie dermatitis, and more
recently in patients with light sensitivity. My former associate Dr. Williams
started working with histamine with the idea of determining its physiologic effect
in the atopie group. The results of these experiments were reported in the
JOURNAL OF INVESTIGATIVE DERMATOLOGY. Skin temperature studies under
accurately controlled conditions were made following the intraeutaneous injec-
tions of histamine in patients with atopie dermatitis and normal individuals. In
the atopie group, following the intraeutaneous injection of histamine there was
an increase in skin temperature in the face, the upper part of the neck, and the
fiexural surfaces of knees and elbows. The temperature at these points would
rise as high as 3.5°C. in the atopie group while in the normal controls there was no
appreciable temperature change in these areas. Accordingly, it seemed that
histamine phosphate had a neuro-vascular action that increased the blood supply
in the areas of predilection in patients with neurodermatitis. The therapeutic
application of histamine on this basis produced variable results.
In the patients with light sensitivity results have been more encouraging
following the use of histamine than in any other dermatosis in which we have
used it. The administration of histamine in 0.2 mgm. dosage given two times a
day for ten days in the early part of summer has carried several of the patients
with light sensitivity through the summer without urtiearial reactions after short
exposures to sunlight. Repeating the course in midsummer has kept them quite
free of skin lesions.
DR. J. GARDNER HOPKINS, New York: I wish Dr. Laymon would tell us a little
more about histaminase and the evidence that this is an enzyme. I would also
like to ask whether after treatment he observed prolonged freedom of symptoms.
This is hard to understand if the substance is a simple enzyme.
S. ROTHMAN, Chicago: Some years ago I had the opportunity to treat S pa-
tients with the German histaminase preparation "Torantil." In these eases of
chronic urtiearia of unknown origin no beneficial effect could be observed. The
mechanism of favorable results reported several times is difficult to understand.
The liberation of histamine as the immediate cause of urticaria eruptions is not
proved definitely. But even if this mechanism is assumed the attack hardly can
be suppressed by histaminase because it does not prevent the histamine
formation.
DR. MARION B. SULZBERGRR, New York: I think Dr. Laymon's presentation
very stimulating and having had a similar experience I can sympathize with the
difficulties of obtaining the material. Moreover, I agree with everything that
Dr. Rothman has just said. I do not believe it possible at present to adhere to
DISCUSSION 311
the theory that all whealing is necessarily due to the liberation of a histamine-like
substance in the skin at the site of the wheal. More evidence is daily piling up
against this hypothetical generalization. Whealing is a very complex phenome-
non and may be of different pathogenesis and mechanism in di1erent instances.
For example, Dr. Harold Abramson showed that if one puts histamine into the
skin by iontophoresis, using one of the poles to force the chemical into the skin
to produce a wheal, and then reverses the current one gets histamine out again.
If however, one takes a wheal produced by the injection or iontophoresis of aller-
gen in sensitive tissue and then attempts to get histamine out by reverse ionto-
phoresis one is uniformly unsuccessful. Many other items of evidence today
caution against the assumption that a histamine-like substance is always liberated
in the production of whealing and that H-substance is the only substance con-
cerned in whealing.
A few years ago Dr. Rostenberg and I attempted some experiments with the
Winthrop Company's histaminase (T 360). We injected histaminase into the
skin and immediately afterwards injected small quantities of histamine. Wheal-
ing at this site was not reduced by the preceding injection of histaminase. We
then used histaminase mixed with allergens. The whealing produced by the
allergens in sensitive skins was not reduced by the fact that we had mixed his-
taminase in our solutions. Moreover, as a third experiment, we incubated his-
taminase with histamine in vitro and got no reduction in whealing as compared
with controls. Thus our results were definitely negative, even as regards the
effect of the ostensible histaminase upon histamine in vitro. We never published
these studies because of difficulties similar to those which Dr. Laymon has de-
scribed; and because the Winthrop Company then recognized that their product
was unstable—and have now prepared and recently placed at our disposal his-
taminase in a more reliable and stable form. However, even in theory the
beautiful concept of histaminase reducing and stopping whealing is not adequate
to explain why, in treating urticarial reactions and urticaria, one should expect
more than a transitory effect through the destruction of histamine. Since even
in theory the method cannot prevent histamine formation, one would expect only
a brief respite when histamine is destroyed, similar to the brief benefit achieved in
urticaria with adrenalin.
I too have found histaminase of some value in certain cases due to photo-
sensitivity. This suggested the possibility of using histaminase in lupus cry-
thematosus and other light-sensitive dermatoses, and we are now proceeding in
this direction.
Da. CARL W. LAYIVION, Minneapolis: The various discussions were greatly
appreciated. I did not mean to give the impression from this presentation that
it was possible to conclude that urticarial wheals are the result of the liberation
of histamine and yet we cannot be entirely sure that histamine does not play some
part in the process.
The exact action of histaminase upon histamine is not known although Best
and McHenry's work indicated that the inactivation of the amine might be due
to splitting up of the iminazole ring.
Dr. Hopkins brought out the point that if the relief in urticaria following the
administration of histaminase were due to inactivation of histamine the lesions
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should recur upon cessation of the drug. This is a difficult question to answer.
Urticaria is a capricious disease and it is well known that even without therapy
the condition may undergo spontaneous remission or cure.
I was glad to hear of Dr. O'Leary's favorable results in cases of hypersensi-
tivity to light. As yet we have not used histaminase in such instances.
As I mentioned in reporting our results, the study was repeatedly interrupted
by inability to procure histaminase. I have been told however that in the near
future ample amounts of the drug will be available and that the new product will
be much superior to that which we have been using.
